Clinical Trial Update: Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 3 trial evaluating the efficacy and safety of Naproxcinod in osteoarthritis of the hip.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Osteoarthritis of the Hip

Drugs mentioned

• Naproxcinod (naproxcinod)

Snippet

Sponsor: NicOx | Conditions: Osteoarthritis, Osteoarthritis, Hip | Phase 3 | Status: COMPLETED